MedTrace Logo

Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis

NCT05393050 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-07-08

No results posted yet for this study

Summary

This study is a multi-center, randomized, double-blinded, controlled trial with two parallel arms. The aim of the study is to evaluate whether Colquhounia Root Tablet combined with methotrexate (MTX) might be better than MTX alone for patients with active rheumatoid arthritis (RA).

Conditions

Interventions

DRUG

Colquhounia Root Tablet

Colquhounia Root Tablet is a tripterygium preparation

DRUG

Methotrexate tablets

Methotrexate is a drug used to treat rheumatoid arthritis

Sponsors & Collaborators

  • Quan Jiang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05393050 on ClinicalTrials.gov